Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.
about
Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administrationLithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medullaSegment-specific ENaC downregulation in kidney of rats with lithium-induced NDI.Mice lacking mPGES-1 are resistant to lithium-induced polyuria.Aquaporin-2 as a biomarker of distal renal tubular function using lithium as an experimental model.GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment.The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS).Treatment of lithium-induced diabetes insipidus with amiloride.Genetic ablation of aquaporin-2 in the mouse connecting tubules results in defective renal water handling.Renal function during long-term lithium treatment: a cross-sectional and longitudinal study.The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.Effects of chronic lithium administration on renal acid excretion in humans and rats.Renal failure in lithium-treated bipolar disorder: a retrospective cohort study.A review of drug-induced hypernatraemia.Lithium nephrotoxicity.Toxic interaction of lithium carbonate and mefenamic acid.Just the berries: Nephrotoxic drugs.Lithium: a review of its metabolic adverse effects.The 6R's of drug induced nephrotoxicityNephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.Management of lithium toxicity.The impact of long-term lithium treatment on renal function in an outpatient populationLithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes InsipidusRapamycin inhibition of mTORC1 reverses lithium-induced proliferation of renal collecting duct cells.Lower estimated glomerular filtration rates in patients on long term lithium: a comparative study and a meta-analysis of literature.Lithium induces microcysts and polyuria in adolescent rat kidney independent of cyclooxygenase-2.Chronic lithium intoxication: Varying electrocardiogram manifestations.Pharmacologically-induced metabolic acidosis: a review.The science and practice of lithium therapy.The effects of lithium on renal function in older adults--a systematic review.An updated review of the optimal lithium dosage regimen for renal protection.Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.Renal microcysts and lithium.Treatment of lithium intoxication: facing the need for evidence.Lithium in the Kidney: Friend and Foe?Drug Interactions with Lithium: An Update.Molecular mechanisms in lithium-associated renal disease: a systematic review.Risk factors for polyuria in a cross-section of community psychiatric lithium-treated patients.
P2860
Q28330696-C244F3BB-CE83-4E4F-BA3A-0628A3D45BB6Q28367660-9A0608A4-9D4A-4FFB-924A-4C8723802309Q30977527-175345DA-29C4-4127-936F-5622E318E5F2Q33570060-38DA0927-A97E-462E-871F-4C31ADAD5264Q33693214-066FD1C9-0AE9-4663-839F-BF2B26296A8EQ33702416-71246311-1B7B-458B-8221-23D7A2201DF8Q33727794-C5FF56B1-A929-47A1-AE61-4D7B133344CEQ33836470-DDDE627E-779B-45A6-AA65-3975E18D39BBQ33965325-AE87C527-6DE8-404A-9C4D-46D13F9AF0C7Q34566437-54A4448F-09AC-4927-90FA-8EA4E391C58FQ34990769-6EA14538-0DFD-4D2E-99BC-CE9BCBAFB850Q34998063-8E2AA9C7-41E0-4E9B-B91E-BC16553B4FB9Q35094211-72636DC2-05AC-4EB6-B3E1-3F49D3BEF873Q35132107-4BF738AE-B15F-459E-BBC7-25DBE2EFA63AQ35574010-2B0FC3B3-C929-4775-9ACB-3A91DF11BB49Q35686024-074847C9-73DB-444E-AAAA-E68271A86FC8Q35705238-1F3ABD94-7E5D-48DE-9570-B6F1C622E46CQ35788876-4ED540D0-8B57-4A8B-A48C-48BA1DE16C92Q36262539-CA7486A0-93A1-46A4-9F9E-98DCA6759BD2Q36333140-21A5530F-1824-4373-BD3E-9DAEC3F7065BQ36724058-60ABBD03-BC1F-4F2F-9FF4-8D1F5F6716AAQ36731340-7DEB58DD-41E4-4D46-A13D-648636529B33Q36837881-03EFF459-6177-494B-A68D-1849350CF5DCQ36843452-94FA4C2A-E583-4020-9A02-24C421F5DDB3Q37052068-4F3C4B0D-CEF1-485B-B6BF-0CC0E9353FE1Q37234738-7C2A7E61-C73C-4F60-B4A4-5C60EC3BFCE9Q37485830-7286311B-A73A-47DA-B020-E833FA91CC27Q37668476-6FB6F9F1-AC5D-43CB-A746-7442AC742910Q37701000-E5CA74CB-FC23-48D7-97B8-775B54DD2F66Q37732209-321D994E-4E03-4E90-BD6D-347F13C772CBQ37990676-004AA02E-AD0C-417C-883A-9767A67E376FQ37999012-05FF8C4D-9EE3-4CA4-BC77-95CC2B2D0653Q38155979-40C485D4-606E-4252-A59D-7B99B0ABBA68Q38292314-8D3B1276-6BD3-45DE-ACCE-3A72487ABDD1Q38605376-01AA928D-F541-470F-A65C-7B74CB471F99Q38614153-39090D39-0A24-4BA9-82CC-C28287B6621AQ38636263-972DA1E1-4B82-425B-B2A6-D076B9529B25Q38758442-48CCEDC5-747D-46D5-89A7-4B538455EC01Q38847068-BDE111A6-F77A-428E-A759-3C11CCE20EE9Q39152568-D398AFA9-C489-4F65-AA5D-541BDC2D0622
P2860
Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@ast
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@en
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@nl
type
label
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@ast
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@en
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@nl
prefLabel
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@ast
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@en
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@nl
P2093
P1476
Prevalence, pathogenesis, and ...... with chronic lithium therapy.
@en
P2093
P304
P356
10.1016/S0272-6386(87)80098-7
P577
1987-11-01T00:00:00Z